Search

Your search keyword '"Michael Chiarella"' showing total 1 results
Start Over Author "Michael Chiarella" Publisher ferrata storti foundation (haematologica)
1 results on '"Michael Chiarella"'

1. Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm

Author

Bart L. Scott, Kaysey F. Orlowski, Pamela S. Becker, Mary-Elizabeth M. Percival, Paul C. Hendrie, Arthur C. Louie, Elihu H. Estey, Emily N. McDaniel, Roland B. Walter, Megan Othus, Bruno C. Medeiros, and Michael Chiarella

Subjects
Oncology, medicine.medical_specialty, Myeloid, Daunorubicin, business.industry, Myeloid leukemia, Hematology, medicine.disease, Myeloid Neoplasm, 03 medical and health sciences, Leukemia, 0302 clinical medicine, medicine.anatomical_structure, Refractory, hemic and lymphatic diseases, 030220 oncology & carcinogenesis, Internal medicine, medicine, Cytarabine, Online Only Articles, business, Survival analysis, 030215 immunology, medicine.drug
Abstract

The need for new therapies for medically less fit adults with acute myeloid leukemia (AML) is unquestioned.[1][1] CPX-351, a liposomal formulation of cytarabine and daunorubicin,[2][2] may be an attractive option. In patients with relapsed/refractory leukemia, in whom CPX-351 was administered on

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results